Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 2
2008 1
2010 4
2011 3
2013 1
2015 2
2016 1
2019 3
2020 1
2021 2
2022 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Results by year

Filters applied: . Clear all
Page 1
Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study.
Piccini JP, Caso V, Connolly SJ, Fox KAA, Oldgren J, Jones WS, Gorog DA, Durdil V, Viethen T, Neumann C, Mundl H, Patel MR; PACIFIC-AF Investigators. Piccini JP, et al. Lancet. 2022 Apr 9;399(10333):1383-1390. doi: 10.1016/S0140-6736(22)00456-1. Epub 2022 Apr 3. Lancet. 2022. PMID: 35385695 Clinical Trial.
Effect of SGLT-2 inhibitors on arrhythmia events: insight from an updated secondary analysis of > 80,000 patients (the SGLT2i-Arrhythmias and Sudden Cardiac Death).
Liao J, Ebrahimi R, Ling Z, Meyer C, Martinek M, Sommer P, Futyma P, Di Vece D, Schratter A, Acou WJ, Zhu L, Kiuchi MG, Liu S, Yin Y, Pürerfellner H, Templin C, Chen S. Liao J, et al. Among authors: schratter a. Cardiovasc Diabetol. 2024 Feb 24;23(1):78. doi: 10.1186/s12933-024-02137-x. Cardiovasc Diabetol. 2024. PMID: 38402177 Free PMC article.
Anticoagulation in atrial fibrillation and liver disease: a pooled-analysis of >20 000 patients.
Chen S, Pürerfellner H, Meyer C, Sommer P, Kiuchi MG, Martinek M, Futyma P, Zanchi S, Zhu L, Schratter A, Wang J, Acou WJ, Liu S, Ling Z, Yin Y, Ouyang F, Chun JKR, Schmidt B. Chen S, et al. Among authors: schratter a. Eur Heart J Cardiovasc Pharmacother. 2022 Jun 8;8(4):336-345. doi: 10.1093/ehjcvp/pvab032. Eur Heart J Cardiovasc Pharmacother. 2022. PMID: 33871577
Adjunctive Left Atrial Posterior Wall Isolation in Treating Atrial Fibrillation: Insight From a Large Secondary Analysis.
Jiang X, Liao J, Ling Z, Meyer C, Sommer P, Futyma P, Martinek M, Schratter A, Acou WJ, Wang J, Zhu L, Kiuchi MG, Pürerfellner H, Schmidt B, Chun JKR, Yin Y, Chen S. Jiang X, et al. Among authors: schratter a. JACC Clin Electrophysiol. 2022 May;8(5):605-618. doi: 10.1016/j.jacep.2022.02.001. Epub 2022 Mar 30. JACC Clin Electrophysiol. 2022. PMID: 35589173 Free article.
Synergy of pulmonary vein isolation and catheter renal denervation in atrial fibrillation complicated with uncontrolled hypertension: Mapping the renal sympathetic nerve and pulmonary vein (the pulmonary vein isolation plus renal denervation strategy)?
Chen S, Kiuchi MG, Yin Y, Liu S, Schratter A, Acou WJ, Meyer C, Pürerfellner H, Chun KRJ, Schmidt B. Chen S, et al. Among authors: schratter a. J Cardiovasc Electrophysiol. 2019 May;30(5):658-667. doi: 10.1111/jce.13858. Epub 2019 Feb 2. J Cardiovasc Electrophysiol. 2019. PMID: 30680830
23 results